Author Guidelines
Preparation of manuscripts
Manuscripts should be prepared using 12-point by employing Microsoft Word. The manuscript should be
organized as follows:
Title page
Title is the first page of the manuscript, it should provide
(a) title of the manuscript
(b) full name of all authors
(c) full addresses of the departments and institutions where the work was performed
(d) a running head with 70 characters inclusive of spaces
(e) name, address, telephone and fax numbers, and e-mail address of the
corresponding author.
Abstract
On the second page, repeat names of the authors and the manuscript's title at the top of the page followed by the
Abstract. The abstract should be structured, without headings into "Introduction", "Objective," "Methods," "Results" and "Conclusion."
Keywords not exceeding 5 should be indicated.
Main body text
The main body of the manuscript should consist of
(a) Introduction
(b) Materials and Methods, Subjects, Patients, whichever is applicable
(c) Results
(d) Discussion
(d) Acknowledgments, if applicable
(e) References.
(a) Introduction
This section should contain the study objectives, rationale, problem statement and previous works of other researchers. Materials and Methods: This section should include description of the methods used in the study. If the study uses the previously reported method, a brief description with reference is enough. The study involving
experimental animals and human subjects/patients should conforms with the "Guide for the Care and Use of Laboratory Animals" and "Declaration of Helsinki (NIH Publication No. 85-23)" Cardiovascular Research 1997; 35: 2-4), respectfully.
(b) Materials and Methods
This section should include description of the methods used in the study. If the study uses the previously reported method, a brief description with reference is enough. The study involving experimental animals and human subjects/patients should conforms with the "Guide for the Care and Use of Laboratory Animals" and "Declaration of Helsinki (NIH Publication No. 85-23)" Cardiovascular Research 1997; 35: 2-4), respectfully.
(c) Results
The data are presented in Results section. Use either Tables or Figures for presentation of data. The data given in Tables or Figures should not be repeated in the main body of the text. The Tables, labelled as Roman numbers and Figures, labelled as Arabic numbers should bear self-explanatory legends/captions and should be embedded nearest where they are referred in the text. SI units should be used. The Figures should be of resolution of 300 dpi or higher. The size of the text, letter or mark in the Figures should be appropriate to withstand reduction.
(d) Discussion
This section can be combined with Results section. It should contain explanation or the reasoning of the findings of the research as compared to the previous findings, if any.
(e) Acknowledgments
The help of the individuals other than the authors should be included in this Section. Any research support from any source must be acknowledged in the Acknowledgments section. References: The reference should be verifiable and correct citation is the responsibility of the submitting author. The references should be cited in the text by last name for single author, two names for two authors with ‘and' in between and name of author with et al for more than two authors followed by the year in ascending chronological order.
(f) References
Reference style is as follows:
Papers
Amidon, G.L., Lennernas, H., Shah, V.P. and Crison, J. R. (1995). A theoretical basis for the biopharmaceutic drug classification. The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research. 12(3), 413-420.
Books
Aulton, M. E (2002). Pharmaceutics: The Science of Dsage Form Design (2nd ed.), Churchill Livingstone, Edinburgh. pp. 211-274.
Ashford, M. (2002). Introduction to biopharmaceutics. In: Aulton, M. E. (Ed.), Pharmaceutics: The Science of
Dosage Form Design (2nd ed.), Churchill Livingstone Edinburgh. pp. 211-274.
Thesis
Pereira, R. E. V (2008). pH sensitive nanoparticles as carriers for oral delivery of a model peptidomimetic
drug. PhD thesis submitted, University Technology MARA, ShahAlam, Malaysia.
Webpage/Data bases
The information should be retrievable through the citation. The author name, if any is to be stated followed by the web address and the retrieval date.
References can also be cited using American Psychological Association 6.
Manuscript submission
Manuscripts should be submitted electronically by the corresponding author at pjp.pharmacy@pu.edu.pk
Cover letter
The covering letter should indicate the category of the manuscript as original article, short communication or review article. It must also include declaration that the manuscript is original, has not published or under review process elsewhere, that the co-author(s) has read the manuscript and approved its submission to the Journal and that, in case of publication, the authors are agree to transfer its copyright to the Pakistan Journal of Pharmacy. The Journal also requires disclosing of any conflict, financial arrangements with commercial companies. The cover letter should be signed by all authors and mailed or faxed to the Office of the Pakistan Journal of Pharmacy. Attachment of the signed cover letter as scanned document with the submission is also acceptable.
For any question, the office of the Journal may be contacted at the following address.
Dr. Nadeem Irfan Bukhari
Office of the Pakistan Journal of Pharmacy
University College of Pharmacy,
University of the Punjab,
Allama Iqbal Campus,
Lahore 54000 Pakistan
Tel: 042-99211616 (0092-42-99211616 from outside Pakistan)
Fax: 042-99211624 (0092-42-99211624 from outside Pakistan)
Email: nadeem_irfan@hotmail.com
